IRadimed Corporation
IRMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $21 | $20 | $20 | $19 |
| % Growth | 3.9% | 4.6% | 0.6% | – |
| Cost of Goods Sold | $5 | $4 | $5 | $5 |
| Gross Profit | $16 | $16 | $15 | $15 |
| % Margin | 77.8% | 78.2% | 76.1% | 76.1% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $4 | $5 | $4 |
| SG&A Expenses | $9 | $8 | $9 | $8 |
| Sales & Mktg Exp. | $0 | $4 | $4 | $5 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10 | $9 | $9 | $9 |
| Operating Income | $7 | $7 | $5 | $6 |
| % Margin | 32.2% | 33.3% | 27.8% | 29.9% |
| Other Income/Exp. Net | $0 | $1 | $1 | $1 |
| Pre-Tax Income | $7 | $7 | $6 | $6 |
| Tax Expense | $2 | $2 | $1 | $1 |
| Net Income | $6 | $6 | $5 | $5 |
| % Margin | 26.3% | 28.3% | 24% | 26.5% |
| EPS | 0.438 | 0.45 | 0.37 | 0.41 |
| % Growth | -2.6% | 21.6% | -9.8% | – |
| EPS Diluted | 0.434 | 0.45 | 0.37 | 0.4 |
| Weighted Avg Shares Out | 13 | 13 | 13 | 13 |
| Weighted Avg Shares Out Dil | 13 | 13 | 13 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $0 | $0 |
| EBITDA | $8 | $8 | $6 | $7 |
| % Margin | 36.2% | 38.8% | 28.8% | 33.7% |